White Papers and eBooks

How to Address Intellectual and Emotional Needs Throughout the Patient Journey

Conversations and engagement stimulate ideas, influence opinions, and impact future decisions. This new infographic illustrates opportunities to use digital and social marketing to create a more engaging, interactive environment for patients and caregivers. Aligning your marketing tactics with interactions at each stage of the patient journey helps...


8 Tips for Capitalizing on New Patient Behaviors in Social and Digital Media

Healthcare is at a pivotal moment as consumer expectations soar and the digital habits that accelerated in lockdown remain. Discover how pharma brands can leverage the age-old need for connection, with the newest tools and technology, for a new and effective digitally forward patient experience. The goal behind every tactic is simple: drive faster,...


Navigating the Future of Patient Engagement

Consumer’s new affinity for digital, mobile, video, and social has changed the healthcare landscape permanently. Like every great evolution, there is no going back. Download the definitive guidebook on how pharma and healthcare brands can leverage the age-old need for connection using the newest tools and technology for a contemporary and effective...


White Paper: Multi Channel Marketing Musts

Insights-Led, Nimble Activation Drives Results for Your Marketing Strategy Valuable Primers and Real World Cases Summary: As a result of a global pandemic and advances in telemedicine and other digital avenues of engagement, more and more patients are seeking options for remote care. The platforms and technologies that patients are using to engage...


Learn How Speeding the Journey Doesn’t Have to Mean Sacrificing Quality and Nuance: eBook — The Patient Journey Evolved

Understanding the patient journey—from symptoms, to diagnosis, and treatment—is a standard and essential part of a life sciences company’s business practice. The information gleaned assists in patient and physician segmentation, forecasting, and building a marketing plan for upcoming and newly launched products, and is often updated annually to...


Whitepaper: Amplity's Blended Engagement Model

A New Post-COVID19 Health Care Provider (HCP) Customer Engagement Approach for Pharma Summary: The COVID pandemic has been the catalyst to change the way the pharmaceutical industry (Pharma) engages with Health Care Providers (HCP). HCP information-seeking needs and preferences have changed dramatically in response to the outbreak, as have the options...


Whitepaper: Join InStep Health as They Discuss Finding Success During the Pandemic

Since the Pandemic Began.. The phrase "uncertain times" has frequently been used to describe our shared sense of confusion, fear, and anxiety regarding COVID-19. During this period we have become accustomed to the disproportionate weight of having more questions than answers. At second glance, through applied quantitative measurements, marketers may...


White Paper: CMO’s Dilemma: What Will Be the “New Normal”?

It remains no secret that Pharma marketing is in a state of flux, precipitated by the COVID-19 pandemic. Virtual Channels, Promotion and Messaging are the Only Option Now. With this as a backdrop, the graphic below serves as an introductory glimpse into the latest edition of SRI’s  Virtual Viewpoint: CMO’s Dilemma: What Will Be the “New Normal”,...


White Paper: 10 essentials every pharma marketer must utilize when emailing physicians

Social distancing and quarantine have only reinforced what many marketers already know: email is king. It yields 50% savings compared to print marketing, and can boast average open rates of over 13% while allowing for tracking on an individual level. But crafting emails to healthcare practitioners (HCPs) is less a science than an art. And HCPs are always...


Whitepaper: Revolution, Evolution Or Agile Solution

How will pharma engage with customers in a post-COVID-19 world? In this whitepaper, we look at how the pharma industry is communicating with healthcare professionals and assess what the future holds for the pharma commercial interaction model. As with so many sectors, the coronavirus pandemic has had a profound impact on the healthcare industry. Currently...


Are We Missing the Magic?

What Behavioral Science can tell us about communications research  Is traditional advertising’s concept-testing research working as well as it could? Is it time to rethink our approach? This white paper explores how behavioral science can uncover the flaws of traditional communications research and offer an advanced, alternative approach to harnessing...


White Paper: Why precision therapies require a precision approach to marketing

Explore how to target specialized providers when and where they’re most likely to engage. Learn the keys to effective marketing campaigns that can cut through the messaging clutter, address unmet physician needs and serve as a key component to the commercial success of precision therapies. Commentary from Eli Phillips, Jr. (Vice President, Regulatory...


Influence and Inspire Action: Performance-Driven Medical Education

Every interaction matters: Promotional medical education that influences and inspires action Pharma companies are missing valuable opportunities with physicians. Did you know that 80% of the content provided by pharmaceutical companies is not what healthcare professionals (HCPs) want? Provider interactions are not being maximized. Promotional medical...